Literature DB >> 21840659

Study of impurity carryover and impurity profile in Febuxostat drug substance by LC-MS/MS technique.

Mustakhusen H Kadivar1, Praveen Kumar Sinha, Dharmendra Kushwah, Pijush Jana, Hitesh Sharma, Atul Bapodra.   

Abstract

Febuxostat is used in the treatment of hyperuricemia and gout. Several impurities were detected in Febuxostat drug substance. Impurities were identified with the help of LC-MS/MS and were characterized after synthesis by IR and NMR. Reverse phase gradient system was used with Kromasil C18, 150mm×4.6mm, 5μm particle size column for the separation of impurities. Q-TOF mass spectrometer with electrospray ionization (ESI) source was used and operated in ESI positive mode, which gives exact mass up to four decimal places and fragmentation with mass accuracy, it is useful for the identification of impurities. Four impurities were identified as amide, sec-butyl, des-cyano and des-acid in Febuxostat drug analog. These impurities were further confirmed by NMR and FT-IR spectral data.
Copyright © 2011. Published by Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21840659     DOI: 10.1016/j.jpba.2011.07.039

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  1 in total

1.  Bioequivalance and pharmacokinetic study of febuxostat in human plasma by using LC-MS/MS with liquid liquid extraction method.

Authors:  Babu Rao Chandu; Kanchanamala Kanala; Nagiat T Hwisa; Prakash Katakam; Mukkanti Khagga
Journal:  Springerplus       Date:  2013-04-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.